J. Raoul

E. Baudin, C. Lombard-Bohas, P. Ruszniewski, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors

M. Cuggia, A. Devillers, J. Raoul, 2009, Journal of Nuclear Medicine.

Research reporting standards for radioembolization of hepatic malignancies.

D. Sze, A. Benson, G. Antoch, 2011, Journal of vascular and interventional radiology : JVIR.

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

J. Pignon, M. Ducreux, V. Boige, 2013, European journal of cancer.

A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02/FFCD9802)

M. Ychou, J. Douillard, Y. Bécouarn, 2005 .

Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors

P. Niccoli, L. Mineur, J. Raoul, 2021, AntiCancer Research.

“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort

R. Anty, J. Raoul, M. Bourlière, 2020, World journal of hepatology.

Usefulness of the MESH score in a European hepatocellular carcinoma cohort

J. Raoul, M. Bourlière, G. Pénaranda, 2017, World journal of hepatology.

Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.

J. Raoul, M. Bourlière, G. Pénaranda, 2019, European journal of gastroenterology & hepatology.

One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization.

J. Raoul, G. Monges, J. Delpero, 2014, World journal of gastroenterology.

Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma

F. Bertucci, J. Raoul, F. Poizat, 2013, BMC Cancer.

Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

J. Raoul, B. Launois, M. Ramée, 1997, Gut.

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts

J. Qi, J. Bradner, J. Iovanna, 2017, EMBO molecular medicine.

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

J. Raoul, M. Bourlière, G. Pénaranda, 2019, Liver Cancer.

Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer

J. Raoul, C. Leroux, M. Pracht, 2011, Medical oncology.

Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen.

S. Bayat, J. Raoul, F. Gaboriau, 2010, Nuclear medicine and biology.

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation

K. Boudjema, Y. Rolland, J. Raoul, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination.

J. Raoul, M. Blayau, J. Campion, 2001, European journal of gastroenterology & hepatology.

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

J. Raoul, P. Michel, X. Mirabel, 2006, British Journal of Cancer.

Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma.

R. Benamouzig, J. Rautureau, J. Raoul, 1995, Gastroenterology.

Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C results from a French multicenter study

J. Blanc, J. Raoul, M. Bourlière, 2015, European journal of gastroenterology & hepatology.

Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.

K. Boudjema, J. Raoul, P. Compagnon, 2005, Journal of the American College of Surgeons.

Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy.

D. Heresbach, L. Siproudhis, J. Raoul, 1992, Gut.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Y. Bang, E. Van Cutsem, E. Raymond, 2011, The New England journal of medicine.

Modalities and indications of locoregional treatments in digestive neuroendocrine tumours

P. Niccoli, J. Raoul, M. Gilabert, 2012 .

Patient-reported outcomes (PROs) in patients (pts) with pancreatic neuroendocrine tumors (NET) receiving sunitinib (SU) in a phase III trial.

Y. Bang, E. Raymond, A. Vinik, 2010 .

Automation of labelling of Lipiodol with high-activity generator-produced 188Re.

J. Raoul, N. Lepareur, V. Ardisson, 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

M. Cuggia, A. Devillers, J. Raoul, 2014, The Journal of Nuclear Medicine.

Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

M. Cuggia, A. Devillers, J. Raoul, 2014 .

Recent Advances in Bioinformatics Reveal the Molecular Heterogeneity of Hepatocellular Carcinoma

T. Murakami, T. Ichikawa, K. Sano, 2014, Liver Cancer.

Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.

D. Lacombe, P. Bachmann, P. Fumoleau, 2003, European journal of cancer.

Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma.

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Scandinavian journal of gastroenterology.

Indium scanning in assessment of acute Crohn's disease

D. Heresbach, L. Siproudhis, A. Devillers, 1993, Digestive Diseases and Sciences.

Expression of MAGE genes in esophageal squamous-cell carcinoma.

Quillien, D. Heresbach, F. Brasseur, 1997, Anticancer research.

6569 POSTER Updated Overall Survival Data From a Phase III Study of Sunltlnlb Vs. Placebo in Patients With Advanced, Unresectable Pancreatic Neuroendocrine Tumour (NET)

E. Raymond, P. Niccoli, J. Valle, 2011 .

Peritoneal Carcinomatosis of Hepatocellular Carcinoma After Resection-Efficacy of Complete Surgical Resection with Hyperthermic Intraperitoneal Chemotherapy

J. Raoul, F. Dumont, É. Thibaudeau, 2020 .

International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study.

J. Jeong, P. Zanzonico, J. Raoul, 2008, Seminars in nuclear medicine.

Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.

J. Jeong, P. Zanzonico, J. Raoul, 2007, International journal of radiation oncology, biology, physics.

Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710.

P. Rougier, J. Raoul, J. Seitz, 2009, Endocrine-related cancer.

An open-label phase II study of first- and second-line treatment with brivanib in patients with hepatocellular carcinoma (HCC).

R. Finn, Yoon-Koo Kang, Joong-Won Park, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.

L. Jeng, M. Kudo, P. Philip, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

To TACE or not to TACE? Lessons from a negative trial.

J. Raoul, M. Gilabert, X. Adhoute, 2017, The lancet. Gastroenterology & hepatology.

Sunitinib (SU) in patients with advanced, progressive pancreatic neuroendocrine tumors (pNET): Final overall survival (OS) results from a phase III randomized study including adjustment for crossover.

Y. Bang, E. Raymond, A. Vinik, 2016 .

Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)

Y. Bang, E. Raymond, A. Vinik, 2012 .

Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET).

E. Van Cutsem, E. Raymond, A. Vinik, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

6501 Sunitinib (SU) vs placebo for treatment of progressive, well- differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

E. Raymond, A. Vinik, P. Metrakos, 2009 .

Metastatic Gastrointestinal Cancer: Safety of Cisplatin Combined with Continuous 5-FU Versus Bolus 5-FU and Leucovorin (Methodology)

M. Ychou, J. Duffour, M. Ducreux, 2008 .

Adjuvant Intraarterial Injection of 131I-Labeled Lipiodol After Resection of Hepatocellular Carcinoma: Progress Report of a Case-Control Study with a 5-Year Minimal Follow-up

K. Boudjema, G. Bouguen, J. Raoul, 2008, Journal of Nuclear Medicine.

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

Masatoshi Kudo, Yoon-Koo Kang, Won Young Tak, 2012 .

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

J. Bruix, M. Sherman, J. Llovet, 2009 .

Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.

M. Kudo, J. Bruix, M. Sherman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metiv-HCC: A phase III clinical trial evaluating tivantinib (ARQ 197), a MET inhibitor, versus placebo as second-line in patients (pts) with MET-high inoperable hepatocellular carcinoma (HCC).

L. Schwartz, C. Porta, J. Bruix, 2013 .

Chemotherapy for Inoperable Advanced or Metastatic Cholangiocarcinoma: Retrospective Analysis of 78 Cases in a Single Center over Four Years

K. Boudjema, J. Raoul, L. Sulpice, 2012, Chemotherapy.

Transient Vision Loss − A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases

J. Raoul, F. Dumont, S. Hiret, 2021, Case Reports in Oncology.

PANERB study: Panitumumab after cetuximab-based regimen failure.

J. Douillard, J. Raoul, J. Metges, 2010 .

Patients with resectable pancreatic adenocarcinoma: A 15-years single tertiary cancer center study of laparotomy findings, treatments and outcomes.

J. Raoul, F. Poizat, J. Delpero, 2018, Surgical oncology.

Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)

P. Rougier, A. Zubel, M. Peeters, 2005 .

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer

M. Mahé, J. Raoul, X. Mirabel, 2021, Cancers.

Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?

J. Raoul, F. Dumont, S. Hiret, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.

J. Raoul, B. Lelièvre, F. Dumont, 2020, European journal of cancer.

Efficacy of 5FU + cisplatin (FUP) compared to bolus 5FU (FU) in advanced pancreatic carcinoma (APC)

J. Pignon, M. Ychou, M. Ducreux, 1999 .

Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901.

C. Mariette, V. Boige, D. Pezet, 2010 .

Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis

P. Soulié, J. Raoul, E. Bompas, 2022, Cancers.

Adjuvant treatment after resection of biliary-tract cancer: yes or no?

K. Boudjema, J. Raoul, M. Pracht, 2011 .

289 Phase II study of cetuximab combined with FOLFIRI (bi-weekly irinotecan plus infusional 5-FU and folinic acid (FA) in patients (pts) with metastatic, Epidermal growth factor receptor (EGFR)-expressing colorectal cancer (CRC)

P. Rougier, J. Raoul, M. Peeters, 2003 .

Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).

M. Ychou, J. Duffour, M. Ducreux, 2006, Anticancer research.

A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'.

J. Raoul, F. Dumont, C. Passot, 2021, European journal of cancer.

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization

Y. Rolland, J. Raoul, P. Bourguet, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Acute ischemia of the lower limb during chemotherapy for testicular cancer: A report of two cases

P. Kerbrat, J. Raoul, E. Vauléon, 2009, Acta oncologica.

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma

J. Raoul, F. Poizat, P. Ries, 2016, Case Reports in Oncology.

Haemolytic uremic syndrome and gemcitabine: Jaundice is not always progression in cholangiocarcinoma

J. Raoul, J. Edeline, O. Audrain, 2012, Acta oncologica.

Cox proportional hazard analysis of sunitinib (SU) efficacy across subgroups of patients (pts) with progressive pancreatic neuroendocrine tumors (NET).

Y. Bang, E. Raymond, C. Lombard-Bohas, 2010 .

[Acinous-cell carcinoma of a metastatic pancreas treated by chemotherapy].

J. Raoul, G. Derrien, E. Boucher, 2002, Gastroenterologie clinique et biologique.

[Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?].

M. Ychou, D. Franco, J. Raoul, 2014, Bulletin du cancer.

Prognostication of HCC under sorafenib: Is it always possible?

J. Raoul, M. Bourlière, G. Pénaranda, 2019, Liver international : official journal of the International Association for the Study of the Liver.

HCC classification and HCC scoring system: a win‐win combination for prognosis and treatment recommendations

J. Raoul, M. Bourlière, G. Pénaranda, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Staging of hepatocellular carcinoma: BCLC system, what else!

J. Raoul, M. Bourlière, G. Pénaranda, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Hepatocellular carcinoma scoring and staging systems. Do we need new tools?

J. Raoul, M. Bourlière, G. Pénaranda, 2016, Journal of hepatology.

Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions

V. Mazzaferro, A. Burroughs, P. Galle, 2012, Seminars in Liver Disease.

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Yan-Shen Shan, Paul Ross, Daniel Palmer, 2016, The Lancet.

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

G. Chatellier, M. Ronot, V. Vilgrain, 2017 .

Management of Esophageal Carcinoma Associated with Cirrhosis: A Retrospective Case-Control Analysis

F. Trivin, J. Raoul, O. Audrain, 2009, Journal of oncology.

Salvage Esophagectomy after Unsuccessful Curative Chemoradiotherapy for Squamous Cell Cancer of the Esophagus

J. Raoul, B. Meunier, B. Launois, 1998, Digestive Surgery.

Radiation-induced oesophageal carcinoma after breast carcinoma: A report of five cases including three successfully treated by radiochemotherapy

J. Raoul, E. Vauléon, E. Boucher, 2007, Acta oncologica.

3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

P. Lebrun, F. Ciardiello, J. Roh, 2007 .

Zollinger-Ellison syndrome, antisecretory treatment, and body weight

D. Heresbach, L. Siproudhis, J. Raoul, 1992, Digestive Diseases and Sciences.

Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial.

J. Douillard, V. Boige, O. Bouché, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Scintigraphic assessment of indium-111-labeled granulocyte splenic pooling: a new approach to inflammatory bowel disease activity.

O. Loréal, J. Raoul, A. Moisan, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].

Y. Deugnier, J. Raoul, P. Bourguet, 1986, Journal de radiologie.

Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.

M. Kudo, H. Shan, H. Lee, 2018 .

New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations

T. Meyer, J. Blanc, J. Raoul, 2022, Cancers.

Prognosis of hepatocellular carcinoma (HCC): Comparison of four staging systems in two French clinical trials

X. Paoletti, P. Rougier, O. Bouché, 2007 .

[Nonsurgical treatment of hepatocellular carcinoma].

P. Kerbrat, J. Raoul, E. Boucher, 1999, Bulletin du cancer.

Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results

Y. Rolland, J. Raoul, H. Mesbah, 2012, The Journal of Nuclear Medicine.

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)

B. Chauffert, M. Ychou, P. Rougier, 2010, Gut.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial

J. Marrero, J. Bruix, J. Llovet, 2008 .

Use of chemotherapy near the end of life for solid cancers: What factors matter?

J. Raoul, L. Morin, P. Rochigneux, 2016 .

3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma

V. Mazzaferro, S. Ricci, J. Llovet, 2007 .

Practice patterns and deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Final analysis of OPTIMIS in Europe and Canada.

A. Cheng, T. Decaens, J. Raoul, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases.

D. Montani, J. Raoul, P. Tattevin, 2011, Chest.

Pneumonia : A Series of 15 Cases I-Labeled Lipiodol-Induced Interstitial 131

J. Raoul, E. Garin, E. Vauléon, 2011 .

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study

J. Raoul, M. Bourlière, G. Pénaranda, 2018, European journal of gastroenterology & hepatology.

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)

T. Conroy, F. Penault-Llorca, M. Campone, 2022, Clinical Medicine Insights. Oncology.

Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides

Y. Rolland, J. Raoul, E. Garin, 2010, Nature Reviews Gastroenterology &Hepatology.

Natural history of hepatocellular carcinoma and current treatment options.

J. Raoul, 2008, Seminars in nuclear medicine.

Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.

K. Boudjema, J. Raoul, D. Olivié, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant intra‐arterial injection of iodine‐131–labeled lipiodol after resection of hepatocellular carcinoma

K. Boudjema, D. Guyader, Y. Rolland, 2003, Hepatology.

Prospective randomized trial of chemoembolization versus intra‐arterial injection of 131I‐labeled–iodized oil in the treatment of hepatocellular carcinoma

D. Guyader, Y. Deugnier, J. Raoul, 1997, Hepatology.

Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).

Y. Bang, E. Raymond, A. Vinik, 2012 .

Evaluation of progression-free survival by blinded independent central review in patients with progressive, well-differentiated pancreatic neuroendocrine tumors treated with sunitinib or placebo.

E. Van Cutsem, E. Raymond, S. Faivre, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated safety and efficacy results of the phase III trial of sunitinib (SU) versus placebo (PBO) for treatment of pancreatic neuroendocrine tumors (NET).

E. Raymond, C. Lombard-Bohas, P. Niccoli, 2010 .

Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.

T. Conroy, M. Ychou, C. Bascoul-Mollevi, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Rachida Lebtahi, Mohamed Bouattour, Christophe Aubé, 2017, The Lancet. Oncology.

An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma

J. Raoul, M. Gilabert, J. Edeline, 2017, Expert opinion on pharmacotherapy.

Immunological study in primary intestinal lymphangiectasia.

D. Heresbach, L. Siproudhis, J. Raoul, 1994, Digestion.

Local injections of granulocyte-macrophage colony-stimulating factor (Gm-CSF) for the treatment of radiation-induced mucosa ulcers.

J. Raoul, E. Boucher, E. Le Prisé, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

R. Lencioni, R. Finn, Yoon-Koo Kang, 2014, Liver Cancer.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

C. Porta, V. Mazzaferro, J. Marrero, 2012, Journal of hepatology.

Bone metastasis revealing hepatocellular carcinoma: a report of three cases with a long clinical course.

J. Raoul, B. Meunier, J. Bretagne, 1995, The American journal of gastroenterology.

A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor

J. Iovanna, N. Dusetti, P. Viens, 2014, Oncotarget.

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.

P. Rougier, V. Boige, O. Bouché, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Lecomte, Sophie Gourgou, T. Conroy, 2018, The New England journal of medicine.

In vitro demonstration of synergy between radionuclide and chemotherapy.

G. Lescoat, P. Brissot, J. Raoul, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

J. Iovanna, N. Dusetti, R. Urrutia, 2017, Cell reports.

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

J. Raoul, M. Gilabert, J. Edeline, 2023, ESMO open.

Use of chemotherapy near the end of life: what factors matter?

C. Tournigand, F. Goldwasser, J. Raoul, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Case Report: Two Cases of Metastatic Pancreatoblastoma in Adults: Efficacy of Folfirinox and Implication of the Wnt/β-Catenin Pathway in Genomic Analysis

F. Bertucci, M. Heymann, J. Raoul, 2021, Frontiers in Oncology.

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

T. Conroy, M. Ychou, M. Ducreux, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials.

X. Paoletti, P. Rougier, O. Bouché, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components

F. Bertucci, M. Heymann, J. Raoul, 2021, Frontiers in Oncology.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2017, BMC Medicine.

Treatment of intermediate-stage hepatocellular carcinoma

J. Bruix, A. Forner, J. Raoul, 2014, Nature Reviews Clinical Oncology.

Systemic treatment of hepatocellular carcinoma: standard of care in China and elsewhere.

J. Raoul, J. Edeline, 2020, The Lancet. Oncology.

Defecatory disorders, anorectal and pelvic floor dysfunction: a polygamy?

D. Heresbach, L. Siproudhis, J. Raoul, 1992, International Journal of Colorectal Disease.

[Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].

P. Michel, J. Raoul, M. Bigard, 1994, Gastroenterologie clinique et biologique.

[Endoscopic treatment and extracorporeal lithotripsy in chronic calcifying pancreatitis. Preliminary results in 16 patients].

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Gastroentérologie Clinique et Biologique.

Recurrent cholangitis caused by the migration of pancreatic calculi associated with pancreas divisum.

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Gastrointestinal Endoscopy.

Constipation after rectopexy for rectal prolapse

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Digestive Diseases and Sciences.

Constipation after rectopexy for rectal prolapse where is the obstruction

D. Heresbach, L. Siproudhis, J. Raoul, 1992 .

Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy?

D. Heresbach, J. Raoul, J. Bretagne, 1991, Gastroenterology.

Pseudoaneurysms and bleeding pseudocysts in chronic pancreatitis: Radiological findings and contribution to diagnosis in 8 cases

D. Heresbach, J. Raoul, M. Carsin, 2005, Gastrointestinal Radiology.

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial.

P. Laurent-Puig, F. Penault-Llorca, C. Borg, 2019, European journal of cancer.

Hepatocellular Carcinoma in a Noncirrhotic Liver after Long-Term Use of Danazol for Hereditary Angioedema

J. Raoul, P. Ries, M. Gilabert, 2014, Case Reports in Oncology.

Gastric bypass for malignant esophagotracheal fistula: a series of 21 cases.

J. Raoul, B. Meunier, J. Campion, 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

T. Conroy, D. Peiffert, L. Mineur, 2010, British Journal of Cancer.

How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?

J. Raoul, M. Gilabert, F. Rousseau, 2017, Journal of geriatric oncology.

Geriatric Profile of Elderly Patients Treated For Pancreatic Cancer: The Oncogepan Database

J. Raoul, J. Seitz, J. Delpero, 2017 .

Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma

G. Batist, P. Kavan, J. Raoul, 2017, Medicine.

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.

J. Iovanna, P. Viens, J. Raoul, 2016, Oncotarget.

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.

J. Iovanna, N. Dusetti, P. Viens, 2015, The American journal of pathology.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

B. Esterni, P. Viens, R. Largillier, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Why is pancreatic cancer difficult to treat in the elderly

J. Raoul, A. Gonçalves, O. Turrini, 2012 .

Management of nonsteroidal anti-inflammatory drug-induced upper gastrointestinal bleeding and perforation.

J. Raoul, J. Bretagne, 1995, Digestive diseases.

Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial.

A. Luciani, R. Perdrisot, G. Chatellier, 2017 .

LBA-001Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial.

A. Luciani, R. Perdrisot, G. Chatellier, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

Y. Rolland, J. Raoul, M. Pracht, 2012, Cancer.

How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma

J. Raoul, M. Gilabert, J. Edeline, 2016, World journal of hepatology.

Ethanol lavage of 14 mucinous cysts of the pancreas: A retrospective study in two tertiary centers

J. Raoul, G. Monges, C. Pesenti, 2012, Endoscopic ultrasound.

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

M. Ychou, E. Assenat, C. Borg, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

T. Conroy, J. Douillard, V. Boige, 2014, The Lancet. Oncology.

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

J. Raoul, J. Metges, E. Gamelin, 2017, Seminars in oncology.

High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer

M. Ychou, C. Borel, F. Caroli-Bosc, 2002, Cancer Chemotherapy and Pharmacology.

Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients.

J. Pierga, Y. Bécouarn, J. Raoul, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cementoplasty for painful bone metastases: a series of 42 cases

Y. Rolland, J. Raoul, H. Mesbah, 2012, Medical Oncology.

Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort

J. Blanc, J. Raoul, M. Bourlière, 2017, World journal of gastroenterology.

T. Conroy, C. Bascoul-Mollevi, J. Douillard, 2017, European journal of cancer.

Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials

X. Paoletti, P. Rougier, S. Collette, 2008, Quality of Life Research.

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort

P. Innominato, O. Hentic, J. Blanc, 2015, Annals of Surgical Oncology.

Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.

Y. Deugnier, J. Raoul, P. Bourguet, 1988, Radiology.

Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases.

J. Raoul, P. Bourguet, R. Duvauferrier, 1988, Radiology.

Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.

J. Raoul, O. Capitain, G. Lorimier, 2019, Surgical oncology.

Significance of lymph node involvement in local recurrence of colorectal cancer

J. Raoul, O. Capitain, F. Dumont, 2019, Journal of surgical oncology.

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.

D. Arsène, P. Rougier, B. Buecher, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

B. Esterni, P. Viens, R. Largillier, 2012 .

Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.

F. Bertucci, D. Birnbaum, P. Finetti, 2016, Cancer genomics & proteomics.

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper

J. Raoul, M. Gilabert, J. Edeline, 2022, Cancers.

Dyschezia and rectocele—A marriage of convenience?

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Diseases of the colon and rectum.

How accurate is clinical examination in diagnosing and quantifying pelvirectal disorders? A prospective study in a group of 50 patients complaining of defecatory difficulties

D. Heresbach, J. Vilotte, L. Siproudhis, 1993, Diseases of the colon and rectum.

[Massive lower digestive hemorrhages. Diagnostic and therapeutic approach].

J. Raoul, 1995, Gastroenterologie clinique et biologique.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.

J. Pignon, M. Ychou, M. Ducreux, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of the rate of artificial insemination and paternity knowledge on the genetic gain for French meat sheep breeding programs

J. Elsen, J. Raoul, 2020 .

Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer

J. Raoul, M. Gilabert, C. Guérin-Charbonnel, 2021, JAMA network open.

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)

F. Penault-Llorca, M. Campone, J. Raoul, 2022, Cancers.

Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy

F. Trivin, J. Raoul, E. Boucher, 2004, Acta oncologica.

Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA.

P. Rougier, M. Peeters, J. Raoul, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.

J. Raoul, G. Pénaranda, J. Bronowicki, 2015, Journal of hepatology.

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

V. Mazzaferro, R. Lencioni, A. Forner, 2011, Cancer treatment reviews.

Solid pancreatic tumors in patients younger than 40 years old--experience of a French comprehensive cancer center.

P. Niccoli, J. Raoul, F. Poizat, 2015, Pancreas.

Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis

J. Raoul, T. Matysiak-Budnik, H. Sénellart, 2022, Clinical Case Reports.

Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas

J. Raoul, C. Leroux, O. Audrain, 2010, Acta oncologica.

Distant Lymph Node Metastases in Gastroesophageal Junction Adenocarcinoma: Impact of Endoscopic Ultrasound-Guided Fine-Needle Aspiration

J. Raoul, G. Monges, C. Pesenti, 2013, Endoscopic ultrasound.

[Cystic tumors and endocrine tumor of the pancreas. An unusual association].

D. Heresbach, L. Siproudhis, J. Raoul, 1993, Gastroenterologie clinique et biologique.

[Glucagonoma: a recent series of 7 cases].

J. Raoul, J. Bretagne, E. Vauléon, 2004, Bulletin du cancer.

Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report

J. Raoul, F. Dumont, É. Thibaudeau, 2021, Pleura and peritoneum.

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.

C. Lombard-Bohas, O. Bouché, F. Bonnetain, 2009, European journal of cancer.

Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology.

T. Conroy, P. Rougier, P. Arveux, 2005, Gastroenterologie clinique et biologique.

Chromogranin a Measurement in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma: Screening for False Positives and a Prospective Follow-Up Study

M. Ducreux, E. Baudin, C. Lombard-Bohas, 2011, The International journal of biological markers.

Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process.

J. Raoul, M. Bourlière, G. Pénaranda, 2015, Journal of hepatology.

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond.

M. Kudo, P. Galle, R. Finn, 2018, Cancer treatment reviews.

Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.

D. Guyader, Y. Deugnier, J. Raoul, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results

R. Anty, J. Raoul, M. Bourlière, 2021, World Journal of Clinical Cases.

Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients

J. Raoul, O. Turrini, M. Gilabert, 2016, Journal of Gastrointestinal Cancer.

Geriatric profile of elderly patients treated for pancreatic cancer

C. Julien, J. Raoul, J. Seitz, 2014 .

OPTIMIS: An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).

M. Kudo, H. Lee, A. Cheng, 2014 .

FRI-494-Practice patterns and outcomes of transarterial chemoembolization in patients with hepatocellular carcinoma who were ineligible and eligible for transarterial chemoembolization at inclusion: Global OPTIMIS exploratory analysis

M. Kudo, H. Lee, A. Cheng, 2019, Journal of Hepatology.

Real-world data in patients with hepatocellular carcinoma treated with transarterial chemoembolization: the second interim analysis of OPTIMIS

M. Kudo, H. Lee, A. Cheng, 2018 .

Deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): An exploratory analysis of OPTIMIS—An international observational study assessing the use of sorafenib after TACE.

M. Kudo, H. Lee, A. Cheng, 2018 .

Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

M. Thomas, R. Finn, Joong-Won Park, 2011, Clinical Cancer Research.

“Posterior” gastric vein, okay. But let's not forget the “Collateral” gastric vein

J. Raoul, K. Okuda, J. Bretagne, 1991, Hepatology.

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.

Y. Bang, E. Van Cutsem, E. Raymond, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

FOLFOX alone or combined to rilotumumab or panitumumab as first-line treatment in patients (pts) with advanced gastroesophageal adenocarcinoma (AGEA): An open-label, randomized phase II trial (PRODIGE 17 ACCORD 20 MEGA).

C. Borg, O. Bouché, F. Ghiringhelli, 2015 .

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)

P. Brissot, K. Boudjema, J. Raoul, 2002, Cancer Chemotherapy and Pharmacology.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

J. Douillard, P. Langlet, E. Jobard, 2014, Oncologie.

Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study.

K. Boudjema, J. Raoul, J. Edeline, 2009, World journal of gastroenterology.

Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma.

V. Quillien, J. Raoul, B. Meunier, 1998, Oncology Report.

Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial

A. Bottomley, Y. Bang, E. Raymond, 2016, Targeted Oncology.

Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?

K. Boudjema, Y. Rolland, J. Raoul, 2013, Annals of Surgical Oncology.

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: preliminary results of a randomized placebo-controlled trial (FFCD-ANGH 2001-01 CHOC)

C. Lombard-Bohas, O. Bouché, F. Bonnetain, 2005 .

A phase III randomised trial of LV 5 FU 2 1 irinotecan versus LV 5 FU 2 alone in adjuvant high-risk colon cancer ( FNCLCC Accord 02 / FFCD 9802 )

T. Conroy, M. Ychou, M. Ducreux, 2009 .

[Proton pump inhibitors and cancers: A hazardous association?]

J. Raoul, M. Gilabert, H. Sénellart, 2020 .

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.

T. Conroy, M. Ychou, J. Douillard, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective

J. Zucman‐Rossi, P. Galle, R. Lencioni, 2013, European journal of gastroenterology & hepatology.

Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: results of phase II trial.

K. Boudjema, A. Guillygomarc’h, J. Raoul, 2006, International journal of radiation oncology, biology, physics.

Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma

J. Raoul, M. Gilabert, J. Edeline, 2014, Liver Cancer.

Tonsillar metastasis revealing signet-ring cell carcinoma of the rectum.

J. Raoul, E. Vauléon, E. Boucher, 2008, Gastroenterologie clinique et biologique.

CAS CLINIQUE Tonsillar metastasis revealing signet-ring cell carcinoma of the rectum A case report

J. Raoul, E. Vauléon, E. L. Prisé, 2005 .

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study

C. Lepage, R. Guimbaud, J. Raoul, 2020, British Journal of Cancer.

Comparison of preoperative imaging and pathological findings for pancreatic head adenocarcinoma

P. Bachellier, J. Raoul, J. Delpero, 2017, Medicine.

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study

C. Lepage, R. Guimbaud, J. Raoul, 2020, British Journal of Cancer.

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response

E. Raymond, H. Lenz, S. Faivre, 2017, British Journal of Cancer.

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

J. Raoul, G. Pénaranda, J. Hardwigsen, 2016, World journal of hepatology.

Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma

V. Mazzaferro, R. Lencioni, R. Gish, 2012, Expert review of gastroenterology & hepatology.

Nomogram of the Barcelona Clinic Liver Cancer System: external validation in European patients

J. Raoul, G. Pénaranda, X. Adhoute, 2016, Liver international : official journal of the International Association for the Study of the Liver.

NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization

J. Raoul, G. Pénaranda, J. Bronowicki, 2017, European journal of gastroenterology & hepatology.

Phase III, Randomized, Double-blind Trial of Sunitinib Versus Placebo in Patients With Progressive, Well-differentiated Pancreatic Islet Cell Tumours

Y. Bang, E. Raymond, A. Vinik, 2009 .

Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.

X. Paoletti, P. Rougier, C. Lombard-Bohas, 2011, Journal of hepatology.

Medical oncologists must get more involved in systemic treatment of hepatocellular carcinoma.

L. Rimassa, S. Faivre, J. Raoul, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Optimal assessment of treatment benefit with targeted agents for hepatocellular carcinoma (HCC): An analysis of brivanib phase II data.

R. Finn, J. Raoul, C. Baudelet, 2010 .

Clubbing and Hypertrophic Osteoarthropathy in Two Patients Taking Long-Term Bevacizumab for Metastatic Colorectal Cancer

J. Raoul, M. Pracht, O. Audrain, 2011, Journal of Gastrointestinal Cancer.

Ex vivo right trisegmentectomy with reconstruction of inferior vena cava and "flop" reimplantation.

K. Boudjema, J. Raoul, D. Lechaux, 2002, Journal of the American College of Surgeons.

[Massive hepatic necrosis secondary to treatment of hepatocellular carcinoma by percutaneous alcoholization].

P. Kerbrat, J. Raoul, E. Boucher, 1998, Gastroenterologie clinique et biologique.

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results

J. Raoul, M. Latournerie, M. Pracht, 2013, International journal of hepatology.

Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus.

D. Heresbach, J. Decertaines, V. Quillien, 1997, International journal of oncology.

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Y. Bang, E. Van Cutsem, E. Raymond, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma

V. Gebski, J. Pignon, P. Schlag, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer

J. Borg, P. Viens, M. Aurrand-Lions, 2015, PloS one.

Response to 'the flexible therapeutic approach to the BCLC B stage': Time for scoring systems?

J. Raoul, G. Pénaranda, X. Adhoute, 2017, Journal of hepatology.

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study

F. Bertucci, P. Viens, J. Raoul, 2017, Supportive Care in Cancer.

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients

J. Raoul, C. Pesenti, E. Bories, 2015, Hepatic medicine : evidence and research.

Tu1542 EUS Guided Hepatico-Gastrostomy Using a New Design Partially Covered Stent (GIOBOR Stent)

J. Raoul, C. Pesenti, E. Bories, 2012 .

Hepatocellular Carcinoma: Slow Progress in a Booming Epidemic.

J. Raoul, M. Gilabert, 2017, Journal of oncology practice.

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Y. Vugmeyster, M. Borad, J. Furuse, 2023, Hepatology.

Gastric Ulcer and Cholestasis Following Injection Therapy of Bleeding Duodenal Ulcers

L. Siproudhis, J. Raoul, A. Ropert, 1991, Endoscopy.

Feasibility of Intratumoral Confocal Microscopy under Endoscopic Ultrasound Guidance

J. Raoul, G. Monges, C. Pesenti, 2012, Endoscopic ultrasound.

Retrorectal Mucinous Adenocarcinoma Arising from a Tailgut Cyst: A Case Report

J. Raoul, O. Kerdraon, H. Sénellart, 2021, Case Reports in Oncology.

Reply:

J. Raoul, P. Bourguet, E. Boucher, 2005 .

Prospective randomized trial of chemoembolization versus intra‐arterial injection of 131I‐labeled–iodized oil in the treatment of hepatocellular carcinoma

D. Guyader, Y. Deugnier, J. Raoul, 1997, Hepatology.

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study

T. Conroy, M. Campone, J. Raoul, 2021, Cancers.

Chemoembolization of hepatocellular carcinomas a study of the biodistribution and pharmacokinetics of doxorubicin

D. Heresbach, J. Raoul, P. Bourguet, 1992, Cancer.

[Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin].

D. Heresbach, J. Raoul, J. Bretagne, 1989, Gastroenterologie clinique et biologique.

Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol

Y. Rolland, J. Raoul, S. Becker, 2008, Nuclear medicine communications.

Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma.

J. Raoul, G. Louvel, E. Vauléon, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bazex Syndrome Revealing a Gastric Cancer

J. Raoul, P. Ries, M. Gilabert, 2014, Case Reports in Oncology.

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).

L. Quéro, G. Piessen, O. Bouché, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

46 Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): final results of study FFCD 9803

D. Arsène, O. Bouché, J. Raoul, 2003 .

Solid Pseudopapillary Tumor of the Pancreas: One Case with a Metastatic Evolution in a Caucasian Woman

J. Raoul, F. Poizat, J. Delpero, 2015, Case Reports in Oncology.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .

Development of a SNP panel dedicated to parentage assignment in French sheep populations

B. Servin, G. Tosser-Klopp, J. Raoul, 2017, BMC Genetics.

[Gastroduodenal invagination. Radio-endoscopic aspects].

J. Raoul, J. Bretagne, M. Ramée, 1990, Gastroenterologie clinique et biologique.

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial.

C. Lepage, P. Rougier, M. Hebbar, 2016 .

131-iodine Lipiodol therapy in hepatocellular carcinoma.

J. Raoul, E. Garin, E. Boucher, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].

L. Siproudhis, J. Raoul, P. Bourguet, 1991, Gastroenterologie clinique et biologique.

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma

J. Raoul, M. Gilabert, J. Frenel, 2019, Hepatic oncology.

Non‐invasive diagnostic criteria for hepatocellular carcinoma: The value of contrast washout at imaging and the death of alpha‐fetoprotein

A. Forner, J. Raoul, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

R. Lencioni, R. Finn, Yoon-Koo Kang, 2014, Liver Cancer.

Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol

Y. Rolland, J. Raoul, S. Becker, 2008, Nuclear medicine communications.

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

P. Schirmacher, V. Mazzaferro, V. Vilgrain, 2018, Journal of hepatology.